Amgen (AMGN)

Cash & Short-Term Investments

$13.99B

Quarterly · Period ending: · USD

AMGN logo

AMGN Cash & Short-Term Investments

Latest reported$13.99B
AMGN Quarterly Cash & Short-Term Investments ($66.60M → $13.99B)
High-resolution chart · PNG

AMGN cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amgen Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
2,469,800,000
2,292,400,000
2,028,100,000
1,866,700,000
1,621,100,000
1,479,600,000
1,333,000,000
1,524,000,000
199,600,000
114,100,000
201,100,000
104,100,000
158,000,000
104,600,000
239,100,000
239,900,000
331,000,000
264,800,000
169,300,000
227,000,000
214,200,000
62,400,000
66,700,000
145,000,000
194,900,000
199,000,000
211,300,000
301,500,000
251,600,000
147,700,000
128,500,000
163,000,000
136,300,000
22,000,000
92,000,000
64,000,000
72,800,000
140,100,000
146,500,000
107,100,000
77,700,000
35,700,000
55,200,000
42,300,000
81,700,000
39,200,000
23,200,000
13,200,000
76,800,000
20,700,000
105,600,000
57,600,000
66,600,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.